Conference Coverage
Conference Coverage
Debate: Should Patients With CLL Take Breaks From Targeted Therapies?
Experts on chronic lymphocytic leukemia debated whether or not patients would benefit from discontinuing treatment at times.
Conference Coverage
Ivonescimab: Possible New First-Line Standard in PD-L1–Positive Advanced NSCLC?
The results highlight ivonescimab’s potential to become a ‘new standard of care’ in advanced PD-L1–positive advanced NSCLC, according to an author...
Conference Coverage
Could Aspirin Avert Bad Outcomes in Leukemia?
A preliminary study finds that aspirin reduces the length and cost of hospital stays in patients with leukemia.
Conference Coverage
To Choose the Best First-line Drug for CML, Consider Efficacy and Cost
For treatment value, imatinib remains the CML gold standard: a generic, second-generation TKI that helps improve treatment-free remission rates....
Latest News
Support for Laser Treatment to Reduce NMSC Risk is Increasing
There is a “growing body of research that demonstrates we are improving the health of our patients’ skin with certain types of laser treatments,...
Latest News
Diagnosing, Treating Rashes In Patients on Immune Checkpoint Inhibitors
Cutaneous immune-related adverse events are the most frequently reported and most visible adverse effects of checkpoint inhibition.
Conference Coverage
Outcomes with CDK4/6 Inhibitors Vary in BC
A large Italian study found real-world differences in short-term outcomes among first line CDK4/6 inhibitors palbociclib, ribociclib and...
Latest News
What Does Hormone Receptor Mean in BRCA-Associated BC?
Large international study highlights the impact of hormone receptor status in young women with BRCA-associated breast cancer.
Conference Coverage
LBCL: CAR T Benefits Both Young and Old
Evidence shows that CAR T-cell therapy yields similar survival outcomes for both older and younger patients with large B-cell lymphoma.
Latest News
Black Women With Breast Cancer Face Clinical Inequities
Retrospective analysis finds no clinical trial enrollment, reduced use of targeted treatment, and shortened survival.
Conference Coverage
Risk Stratification May Work Well for FIT-Based CRC Screening in Elderly
Fecal immunochemical tests could play a major role in risk stratification, researchers said.